• Midland infectious disease activity summary (MIDAS), Vol 3 (3), December 2013

      Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health (Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health, 2013-12-11)
    • Midland infectious disease activity summary (MIDAS), Vol 4 (1), June 2014

      Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health (Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health, 2014-06)
    • Midland infectious disease activity summary (MIDAS), Vol 4 (2), December 2014

      Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health (Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health, 2014-12-16)
    • Midland infectious disease activity summary (MIDAS), Vol 5 (1), Oct 2015

      Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health (Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health, 2015-10)
    • Midland infectious disease activity summary (MIDAS), Vol 6 (1), Dec 2016

      Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health (Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Department of Public Health, 2016-12-02)
    • Monaghan Alcohol Related Harm Profile 2017

      Health Service Executive (HSE), Ms, D Goggin, Ms L Cullen, Ms J O’Kane, Ms A Sheridan, Ms M Murphy, Dr. D O’Donovan, Dr. C Mason Mohan.; Alcohol Forum, Mr K Doherty, Ms P Leonard (Health Service Executive (HSE), 2017-05)
    • Monaghan alcohol-related harm profile 2019

      Goggin, Deirdre; Cullen, Louise; O'Kane, Joan; O'Donovan, Diarmuid; Mason Mohan, Caroline; Health Profile Working Group; Health Service Executive (HSE) (Health Service Executive (HSE), 2019-07)
    • Mortality due to SUDEP and Status Epilepticus

      Donohue, F; Doherty, C; Langan, Y; White, M; White, M; Morrow, S; Hayes, C (Irish Medical Journal, 2013-03)
    • National acute medicine programme - improving the care of all medical patients in Ireland

      Orlaith O’Reilly, Fiona Cianci, Avelene Casey, Eilish Croke, Celine Conroy, Anne-Marie Keown, Gemma Leane, Barbara Kearns, Shane O’Neill, Garry Courtney (2015-12)
    • National acute medicine programme poster

      O' Reilly, Orlaith; Casey, Avilene; Courtney, Garry; Keown, Anne-Marie (Health Service Executive (HSE); Royal College of Physicians of Ireland, 2013-04)
    • National COPD (Respiratory) strategy 2008

      Health Service Executive (HSE); Irish Thoracic Society; Irish College of General Practitioners (2008)
    • National COPD (Respiratory) strategy 2008: technical reports

      Health Service Executive (HSE); Irish Thoracic Society; Irish College of General Practitioners (Health Service Excutive (HSE), 2008)
    • The national healthy childhood programme - newsletter 1 Winter 2016

      Health Service Executive (HSE), National Healthy Childhood Programme (2016-12-16)
    • National pandemic influenza plan

      Health Service Executive (HSE), Department of Health and Children (DOHC) (Health Service Executive (HSE), 2007-01)
    • A national study of the retention of Irish opiate users in methadone substitution treatment

      Mullen, Louise; Barry, Joseph; Long, Jean; Keenan, Eamon; Mulholland, Deirdre; Grogan, Loretto; Delargy, Ide; Health Services Executive, Dr. Steeven's Hospital , Dublin , Ireland. (2012-07-02)
      Background: Retention in treatment is a key indicator of methadone treatment success. The study aims to identify factors that are associated with retention. Objectives: To determine retention in treatment at 12 months for Irish opiate users in methadone substitution treatment and to indicate factors that increase the likelihood of retention. Methods: National cohort study of randomly selected opiate users commencing methadone treatment in 1999, 2001, and 2003 (n = 1269). Results: Sixty-one percent of patients attending methadone treatment remained in continuous treatment for more than 1 year. Retention in treatment at 12 months was associated with age, gender, facility type, and methadone dose. Age and gender were no longer significant when adjusted for other variables in the model. Those who attended a specialist site were twice as likely to leave methadone treatment within 12 months compared with those who attended a primary care physician. The most important predictor of retention in treatment was methadone dose. Those who received <60 mg of methadone were three times more likely to leave treatment. Conclusion: Retention in methadone treatment is high in Ireland in a variety of settings. The main factors influencing retention in methadone treatment was an adequate methadone dose and access to a range of treatment settings including from primary care physicians. Scientific Significance: Providing an adequate dose of methadone during treatment will increase the likelihood of treatment retention. Methadone treatment by the primary care physician is a successful method of retaining opioid users in treatment.
    • Need for postgraduate medical training in cultural competence?

      Donohue, Sinéad (Health Service Executive (HSE) East (Dublin, Kildare, Wicklow), Department of Public Health, 2010-09)
    • Neural tube defects in the Republic of Ireland in 2009-11.

      McDonnell, R; Delany, V; O'Mahony, M T; Mullaney, C; Lee, B; Turner, M J; Health Intelligence Unit, Health Service Executive, Dr Steevens Hospital, Dublin 8, Ireland. (2014-03-18)
      Neural tube defects (NTDs) are associated with deficient maternal folic acid peri-conceptionally. In Ireland, there is no mandatory folic acid food fortification, partly due to declining NTD rates in recent years. The aim of this study was to ascertain the incident rate of NTD during the period 2009-11 and describe epidemiologically NTD in Ireland.METHODSCases were ascertained through multiple sources, including three regional congenital anomaly registers, all maternity hospitals nationally and paediatric hospitals providing care for children with spina bifida in the Republic of Ireland during the period 2009-11.RESULTSFrom 225 998 total births, 236 NTDs were identified, giving an incidence of 1.04/1 000 births, increasing from 0.92/1 000 in 2009 to 1.17/1 000 in 2011. Of all cases, 45% (n = 106) had anencephaly, 49% (n = 115) had spina bifida and 6% (n = 15) had an encephalocoele; 78% (n = 184) were liveborn or stillborn and 22% (n = 52) were terminations abroad. Peri-conceptional folic acid supplement intake was 13.7% among the 52.5% (n = 124) of cases whose folic acid supplement intake was known.CONCLUSIONThe incidence of NTDs in the Republic of Ireland appears to be increasing. Renewed public health interventions, including mandatory folic acid food fortification, must be considered to reduce the incidence of NTD.
    • Norovirus outbreak in a university teaching hospital

      O'Meara, M; O'Connor M (Department of Public Health, 2007)